Photo: Joosarang Lee/MSF

World Tuberculosis Day 2017: Govt rollout of TB drug slow, say experts

Medical Research
April 15, 2017

Bedaquiline may be the answer to several drug-resistant patients in India, but the government is extra cautious about the rollout. The drug has been approved for only 600 patients for a six-month regime. Shahida is one among over 200 patients selected so far including 68 in Mumbai.


Click here to read more

Related Medical issues

Related News